(Q39548170)

13 September 2017

1 reference

title

The roles of glucocorticoid and dopaminergic systems in delusional (psychotic) depression (English)

1 reference

13 September 2017

1 reference

1 reference

Schatzberg AF

1

1 reference

13 September 2017

Rothschild AJ

series ordinal

2

1 reference

13 September 2017

language of work or name

English

0 references

publication date

1 January 1988

1 reference

Annals of the New York Academy of Sciences

13 September 2017

1 reference

13 September 2017

537

1 reference

13 September 2017

462-471

1 reference

Activating and 'anxiogenic' effects of corticotropin releasing factor are not inhibited by blockade of the pituitary-adrenal system with dexamethasone

13 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42128.X

Outcome in schizoaffective, psychotic, and nonpsychotic depression. Course during a six- to 24-month follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42128.X

EEG sleep in depressed adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42128.X

The pharmacological treatment of delusional depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42128.X

Hallucinations in patients with major depression. Interactions between CSF monoaminergic and endorphinergic indices

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42128.X

Delusional unipolar depression: description and drug response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42128.X

The clinical use of the dexamethasone suppression test in DSM-III affective disorders: correlation with the severe depressive subtypes of melancholia and psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42128.X

A corticosteroid/dopamine hypothesis for psychotic depression and related states

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42128.X

Computed tomography in affective disorders. Part I. Ventricular and sulcal measurements.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42128.X

Electroencephalographic sleep in psychotic depression. A valid subtype?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42128.X

Psychotic and nonpsychotic depressions: II. Platelet MAO activity, plasma catecholamines, cortisol, and specific symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42128.X

Dexamethasone increases plasma free dopamine in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42128.X

The effects of a single acute dose of dexamethasone on monoamine and metabolite levels in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42128.X

Chronic corticosterone administration in rats: behavioral and biochemical evidence of increased central dopaminergic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42128.X

Psychopathology in Cushing's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42128.X

Depressed Mood and Other Psychiatric Manifestations of Cushingʼs Syndrome: Relationship to Hormone Levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42128.X

Dopaminergic modulation of the septo-hippocampal cholinergic system activity under stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42128.X

Supersensitive endocrine response to physostigmine in dopamine-depleted rats: a model of depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42128.X

The Brain as a Target for Steroid Hormone Action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42128.X

Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients. Correlation with psychosis and response to neuroleptic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42128.X

CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB42128.X

10.1111/J.1749-6632.1988.TB42128.X

21 January 2018

Identifiers

DOI

1 reference

release_xs6zkf7ktzbxnipnhplv64tif4

13 September 2017

0 references

1 reference